HB 4196 requires licensed medication-assisted treatment (MAT) programs in West Virginia to offer long-acting reversible contraception (LARC), such as IUDs or implants, to patients receiving methadone or suboxone for substance use treatment. This applies to all facilities providing these services under the state's licensing framework, adding it as a standard requirement to existing operational rules. The bill directly affects MAT facilities, which must now integrate LARC options into their care protocols, and patients using methadone or suboxone at these locations. It creates a concrete policy change by mandating access to these contraceptive methods without requiring additional patient steps.
HB 4982 reestablishes West Virginia's statewide Healthy Lifestyles program, creating the Office of Healthy Lifestyles within the Department of Health. It directly affects all West Virginia residents, particularly Medicaid members with nutrition-related chronic diseases (like obesity or diabetes), by expanding access to "Food Is Medicine" services such as nutrition counseling, medically tailored meals, and grocery provisions. Key provisions include requiring the Bureau for Medical Services to design nutrition-based interventions to reduce healthcare costs, establishing a Healthy Lifestyle Coalition with 13 members to coordinate state and community efforts, and mandating physical fitness initiatives in schools. The bill also repeals previous program sections and adds new rules to promote nutritious food access and prevent diet-related diseases.
HB 4089, known as "Jessica Huffman's Law," requires health insurers in West Virginia to cover scalp cooling systems for patients undergoing cancer chemotherapy starting January 1, 2027. The bill mandates that any insurance policy covering chemotherapy must include coverage for these devices - described as tools to prevent hair loss during treatment - as defined by Medicare and Medicaid. This applies to policies issued or renewed after 2026, with coverage subject to standard deductibles and coinsurance like other medical benefits. The law directly affects cancer patients seeking hair preservation and insurers offering chemotherapy coverage.
HB 4599 modifies West Virginia's background check variance process under the WV Cares program, primarily affecting healthcare workers and facility employees requiring background checks. The bill establishes that granted variances follow individuals (not employers), extends validity to five years (unless new disqualifying offenses appear), and requires variance reviews to be completed within 30 days. It narrows disqualifying offenses to only those involving abuse, violence, fraud, or safety risks, and creates a single standardized "Fitness Variance Determination" document for employers to use instead of multiple records. All relevant state agencies must update their systems within 180 days to implement these changes.
HB 4009, the Portable Benefit Account Act, creates a new legal framework allowing independent contractors to access portable benefits through individually managed accounts. It directly affects independent contractors and hiring parties (businesses that contract with them), enabling voluntary contributions from hiring parties to fund benefits like health insurance, retirement plans, life insurance, and income replacement. Key provisions require written, opt-in agreements for contributions, prohibit using account contributions to determine worker classification, and mandate that accounts remain tied to the contractor - not the employer - when changing jobs. The bill establishes definitions for terms like "portable benefit account" and "provider," and requires administrative oversight by the Bank Commissioner.
This bill exempts the West Virginia Department of Health from certain state purchasing restrictions when implementing the federal Rural Health Transformation Program. The legislation allows the state to use federal funds more flexibly to meet the program's strict requirements for rapid deployment and specific use of money in rural healthcare areas. By overriding existing state purchasing laws, the bill ensures the Department of Health can comply with federal guidelines from the Centers for Medicare and Medicaid Services without administrative delays. This change directly affects the state's ability to manage federal grants aimed at improving healthcare infrastructure and services in rural communities.
This bill requires physicians and osteopathic doctors in West Virginia to complete continuing education credits specifically in nutrition as part of their biennial license renewal process. The law mandates that medical professionals earn a minimum of fifty hours of continuing medical education every two years, with osteopathic physicians required to complete thirty-two hours including nutrition training, and these credits must be approved by relevant medical boards. The bill amends existing state code sections to make nutrition education a mandatory component of the continuing education requirement for license renewal.
HB 4610 allows terminally ill patients in West Virginia to access experimental, individually tailored medical treatments (like gene therapies) when standard FDA-approved options have been exhausted. It defines "eligible patients" as those with life-threatening illnesses who have consulted a physician, considered all approved treatments, and provided written consent detailing treatment risks and alternatives. Key provisions require healthcare providers to document patient eligibility, obtain specific informed consent covering potential outcomes, and prohibit debt collection from estates if a patient dies during treatment. The bill also protects healthcare providers from sanctions for offering these treatments and clarifies that it does not affect health insurers' obligations to cover clinical trial participation.
HB 4626 establishes a West Virginia grant program to fund U.S. Food and Drug Administration (FDA) drug development trials using ibogaine, a substance being studied for treating opioid use disorder and other neurological/mental health conditions. The program requires applicants (e.g., pharmaceutical companies or research organizations) to demonstrate capacity to conduct FDA trials, secure approval for ibogaine as a medication, and commit to establishing a state presence, securing insurance coverage, and ensuring treatment access for uninsured patients. Applicants must submit detailed trial designs, safety protocols, and plans for intellectual property rights and post-approval implementation, with grants administered through a state selection committee. The bill does not approve ibogaine but aims to accelerate its development pathway through state-funded trials.
HB 4981 designates psychiatric hospitals treating exclusively civil and forensic patients (over 95% court-ordered civil/forensic cases from state custody) as "state-designated facilities" for Medicaid funding purposes. This change allows these specific hospitals to qualify for Medicaid reimbursement under federal rules, rather than being excluded as "state-designated" under current tax code. The bill amends tax provisions to ensure revenue collected from eligible hospitals (via a 0.75% tax on gross receipts) flows directly into a Medicaid funding account. It directly affects licensed psychiatric hospitals meeting the strict patient-mix criteria, enabling them to access Medicaid program funds they previously could not.
